← Evidence map

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy.

Sael AlatawiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41580475